A broadly based, multidisciplinary business sector which is subject to regulation in certain technical areas on a jurisdictional basis, and is impacted by a variety of factors at every level.   

An overriding fundamental issue for the sector is how global food production can be intensified to feed a projected nine billion people by 2050, whilst dealing with impacts of climate change.   

Improvements in efficiency and sustainability in agriculture continue to drive ingenious solutions that harness various cutting-edge technologies, such as genomics and CRISPR gene editing, big data, algorithms and AI.  As such, inventions in this sector increasingly involve crossover technologies, requiring the pooling of expertise and effort amongst HGF’s life scientists, chemists and electronics and software attorneys. 

Regulatory aspects govern many plant protection product inventions, and additional levels of IP protection can be available via Supplementary Protection Certificates (SPCs).  There are also potential Convention on Biological Diversity and Nagoya Protocol constraints which can present particular R & D hurdles, and IP issues for inventions which use certain biological materials and their derivatives.  

HGF has the corresponding necessarily specialised and multidisciplinary team of attorneys and lawyers for dealing with IP in this sector. The AgBio and Agritech team is comprised of technically and commercially experienced attorneys, including senior ex-Global 500 company attorneys who provide additional levels of commercial experience and acumen.  Where IP issues are more legal rather than technical, our team adjusts to include or be led by solicitors who are highly experienced in contract negotiation, litigation or management level briefings on IP issues developing technology areas.    

HGF’s attorneys deal with inventions in accelerated plant breeding procedures, genetically engineered or modified crops, actives and formulations for plant protection products, diagnostics, precision and digital agriculture, genetically engineered or modified animals, improved husbandry methods and carbon neutral systems.

Latest updates

What's Next for CAR Cell Therapy?

The first generation CAR T cell was discovered in 1993 when the variable region of an antibody was fused to the constant regions of a T cell receptor.  Now, 20 …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 23rd - 24th April 2024

Microbiome & Probiotic R&D & Business Collaboration Forum: Europe

The 12th Microbiome & Probiotics R&D and Business Forum will take place from the 23rd-24th April at the Postillion Convention Centre in the Hague, Netherlands. This world-renowned event will see …

Event details

IAM Patent 1000 2023

IAM Patent 1000 the world’s leading patent professionals 2023 guide has now been published and we are delighted to have 31 attorneys recognised as world-class individuals in the guide. The …

Read article

What is EUDAMED and how will it affect your IP strategy?

The “European database on medical devices”, or “EUDAMED”, is the EU’s IT system created by the new Medical Devices Regulation (MDR) and In Vitro Diagnostics Medical Devices Regulation (IVDR). When …

Read article
Event - 8th - 9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 29th November 2022

LSPN Europe 2022

HGF is a silver sponsor of LSPN Europe 2022 on 29th November in London. This event will explore some of the biggest challenges facing the Life Sciences Patent Community right now …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our agbio specialists.